Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.
itye i sold out like you for a big loss
0.90p and these goons are all still positive. Why did Paul say they were profitable when they're not. It was EBITDA he was talkung about which excludes finance costs and depreciation - given its a heavily geared loss making IT company these are essential costs!!
Vorag perhaps you'd like to answer rather than tell people to get off the board?
In the last investor call Paul talked about Operational profitability. Today the results show he meant EBITDA. Completely different!
He also said they returned a profit for the 4th quarter as a whole. Today it's just December!
He said they didn't need more cash. Today they do under stress and have burnt through the last placing.
I've sold out of this dog, but the rest of you should hold him accountable to his last comments.
Blocked for not liking your £25 bucket hat. I can totally understand your frustration. It is a lovely hat.
Someone's getting paid to bag up the merchandise and head out to the post office? I'm glad I'm not invested here. Might do when you get some partners selling fashionable merch though
Is it a joke that we have invested in a company making mugs, hats and t shirts?
https://store.modeapp.com/
New TREATMENTS (not vaccines) on the way. This could be us.
http://news.sky.com/story/covid-19-all-over-18s-in-england-able-to-book-vaccine-dose-by-end-of-this-week-nhs-boss-expects-12333012
As at date of publication, 156 patients have been recruited and have completed treatment. The data is now being assessed and outcomes will be reported formally on or about late July 2021. It is the intention of EML to seek a sale of the drug, a license or partnership deal as soon as possible after the data is published.
The above is from the Angelfish RNS. Late July for final results, which should mean initial indications are ahead of the "end of June" expectation.
The original RNS stated "Vela's Economic Interest shall be renegotiated should SGS receive further funding from third parties in the future."
My take on the £2m placing is Vela will look to maintain its 8% economic interest once trial results are known and SGS look to raise further funds to see this through to production phase.
News expected any day now!
https://www.reuters.com/world/india/black-fungus-complication-adds-indias-covid-woes-2021-05-10/
Original RNS said this had no impact on 7dig or its revenues. Seems pointless to therefore release this update.